SOURCE XT REGISTRY

NCT ID: NCT01238497

Last Updated: 2020-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2954 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This registry is to expand upon existing data sets, to identify patient characteristics and indicators related to complications and clinical benefits for patients with symptomatic severe calcific degenerative aortic stenosis that are undergoing treatment with the commercially available Edwards SAPIEN XT™ Valve, and delivery devices.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Consecutive patient data should be collected at discharge, 30 days and 12 months post-implant. Subsets of patients may undergo additional follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Aortic Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Registry 1 - SOURCE XT

Registry 1: All patients implanted with a SAPIEN XT valve, via Transfemoral access using NovaFlex (for 23mm and 26mm valve), or via Transapical access using Ascendra2 (23mm, 26mm and 29mm valve)

TAVR Implantation of the Transcatheter Aortic Valve Prosthesis

Intervention Type DEVICE

Patients eligible for either transfemoral or transapical access and any of the 3 valve sizes (23, 26 or 29)

Registry 2 - Ascendra+

Registry 2: All patients implanted with a SAPIEN XT Valve, via Transapical or Transaortic access using Ascendra+ delivery system (23mm, 26mm and 29mm valve)

TAVR Implantation of the Transcatheter Aortic Valve Prosthesis

Intervention Type DEVICE

Patients eligible for transapical or transaortic access and any of the 3 valve sizes (23mm, 26mm or 29mm)

Registry 3 - NovaFlex+ 29 mm

Registry 3: All patients implanted with a SAPIEN XT valve, 29mm only, via Transfemoral access using NovaFlex+

TAVR Implantation of the Transcatheter Aortic Valve Prosthesis

Intervention Type DEVICE

Patients eligible for transfemoral access and requiring a 29mm valve.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TAVR Implantation of the Transcatheter Aortic Valve Prosthesis

Patients eligible for either transfemoral or transapical access and any of the 3 valve sizes (23, 26 or 29)

Intervention Type DEVICE

TAVR Implantation of the Transcatheter Aortic Valve Prosthesis

Patients eligible for transapical or transaortic access and any of the 3 valve sizes (23mm, 26mm or 29mm)

Intervention Type DEVICE

TAVR Implantation of the Transcatheter Aortic Valve Prosthesis

Patients eligible for transfemoral access and requiring a 29mm valve.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TAVI Transcatheter Aortic Valve Implantation TAVI Transcatheter Aortic Valve Implantation TAVI Transcatheter Aortic Valve Implantation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The SAPIEN XT™ THV is indicated for use in patients with symptomatic aortic stenosis requiring TAVI who have a high risk for operative mortality, or are "non-operable"

Exclusion Criteria

* Non-valvular or congenital aortic stenosis
* Pre-existing prosthetic heart valve in the Aortic position or a non-calcified aortic valve
* Severe (\>3+) mitral insufficiency or aortic regurgitation \> 3+
* Active bacterial endocarditis or other active infections
* Severe ventricular dysfunction with ejection fraction \< 20%
* Coronary artery disease-related unstable angina
* Inability to tolerate anticoagulation / antiplatelet therapy
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Edwards Lifesciences

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olaf Wendler, MD, PhD, FRCS

Role: PRINCIPAL_INVESTIGATOR

[email protected]

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitatsklinik Innsbruck

Innsbruck, , Austria

Site Status

Medical University Vienna

Vienna, , Austria

Site Status

Onze Lieve Vrouw Ziekenhuis

Aalst, , Belgium

Site Status

Clinique St Luc

Bouge, , Belgium

Site Status

Cliniques Universitaires Saint Luc

Brussels, , Belgium

Site Status

Universitaire Ziekenhuizen Leuven

Leuven, , Belgium

Site Status

Foothills Medical Centre

Calgary, Alberta, Canada

Site Status

University of Alberta Hospital

Edmonton, Alberta, Canada

Site Status

St. Paul's Hospital

Vancouver, British Columbia, Canada

Site Status

St. John Regional Hospital

Saint John, New Brunswick, Canada

Site Status

Hamilton Health Services

Hamilton, Ontario, Canada

Site Status

Southlake Hospital

Newmarket, Ontario, Canada

Site Status

Toronto General Hospital

Toronto, Ontario, Canada

Site Status

Montreal Heart Institute

Montreal, Quebec, Canada

Site Status

Centre Hospitalier De Universite of Montreal

Montreal, Quebec, Canada

Site Status

Hospital Laval

Sainte-Foy, Quebec, Canada

Site Status

University of Hradec Kralove

Hradec Králové, , Czechia

Site Status

Aarhus University Hospital

Aarhus, , Denmark

Site Status

Helsinki University Central Hospital

Helsinki, , Finland

Site Status

Tampere University Hospital

Tampere, , Finland

Site Status

CHU Jean Minjoz

Besançon, , France

Site Status

CHU La Cavalle Blanche

Brest, , France

Site Status

Hôpital Privé Parly II

Le Chesnay, , France

Site Status

Centre Chirurgical Marie Lannelongue

Le Plessis-Robinson, , France

Site Status

CHU La Timone

Marseille, , France

Site Status

Hôpital St Joseph

Marseille, , France

Site Status

Clinique Clairval

Marseille, , France

Site Status

Institut Hospitalier Jacques Cartier

Massy, , France

Site Status

CHU Montpellier - Hôpital Arnaud de Villeneuve

Montpellier, , France

Site Status

Hopital Nord Laënnec

Nantes, , France

Site Status

Hopital Bichat

Paris, , France

Site Status

CHRU Pontchaillou

Rennes, , France

Site Status

C.H.U Charles Nicolle

Rouen, , France

Site Status

CHU Rangueil

Toulouse, , France

Site Status

Clinique Pasteur / GCVI

Toulouse, , France

Site Status

Clinique Saint-Gatien

Tours, , France

Site Status

Zentralklinik Bad Berka GmbH

Bad Berka, , Germany

Site Status

Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH

Bad Krozingen, , Germany

Site Status

Kerckhoff Klinik

Bad Nauheim, , Germany

Site Status

Herz- und Gefäss-Klinik GmbH

Bad Neustadt an der Saale, , Germany

Site Status

Herz- und Diabeteszentrum NRW

Bad Oyenhausen, , Germany

Site Status

Evangelisch Freikirchliches Krankenhaus

Bernau, , Germany

Site Status

Universitätsklinikum

Cologne, , Germany

Site Status

Städtisches Klinikum

Dortmund, , Germany

Site Status

Herzzentrum Dresden GmbH Universitätsklinik

Dresden, , Germany

Site Status

Universitätsklinik Erlangen

Erlangen, , Germany

Site Status

Universitätsklinikum Essen

Essen, , Germany

Site Status

Universitatsmedizin Gottingen

Göttingen, , Germany

Site Status

Asklepios Klinik St Georg

Hamburg, , Germany

Site Status

Universitatsklinikum Eppendorf

Hamburg, , Germany

Site Status

Universitätsklinikum

Jena, , Germany

Site Status

KLINIKUM KARLSBURG der Klinikgruppe Dr. Guth GmbH & Co. KG

Karlsburg, , Germany

Site Status

Städtisches Klinikum Karlsruhe

Karlsruhe, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein, Campus Kiel

Kiel, , Germany

Site Status

Herzzentrum Leipzig GmbH

Leipzig, , Germany

Site Status

Johannes Gutenberg Universität Mainz

Mainz, , Germany

Site Status

Deutsches Herzzentrum Muenchen

Munich, , Germany

Site Status

Klinikum Schwabing

Munich, , Germany

Site Status

Klinikum der Universität München - Großhadern

Munich, , Germany

Site Status

Klinikum Bogenhausen

Munich, , Germany

Site Status

Universitätsklinikum Münster

Münster, , Germany

Site Status

Klinikum Sud Nurnberg

Nuremberg, , Germany

Site Status

Universitatsklinikum Regensburg

Regensburg, , Germany

Site Status

SANA Herzzentrum

Stuttgart, , Germany

Site Status

Universitatsklinik Wurzburg

Würzburg, , Germany

Site Status

Hygeia Hospital

Athens, , Greece

Site Status

Rambam Medical Center

Haifa, , Israel

Site Status

Shaare Zedek

Jerusalem, , Israel

Site Status

Rabin Medical Center

Petah Tikva, , Israel

Site Status

The Chaim Sheba Medical Center

Tel Litwinsky, , Israel

Site Status

Clinica Sant'Anna Hospital

Catanzaro, , Italy

Site Status

Ospedale Pasquinucci

Massa, , Italy

Site Status

Clinica Montevergine

Mercogliano, , Italy

Site Status

Ospedale San Raffaele

Milan, , Italy

Site Status

Centro Cardiologico Monzino

Milan, , Italy

Site Status

Hesperia Hospital

Modena, , Italy

Site Status

Azienda Ospedaliera Policlinico Universitario

Padua, , Italy

Site Status

Istituto Clinico Humanitas

Rozzano Milano, , Italy

Site Status

Ospedale San Giovanni Battista

Torino, , Italy

Site Status

Maastricht UMC+

Maastricht, , Netherlands

Site Status

Universitetssykehuset Nord-Norge

Tromsø, , Norway

Site Status

The Cardinal Stefan Wyszyński Institute of Cardiology

Warsaw, , Poland

Site Status

Sunninghill Hospital

Johannesburg, Gauteng, South Africa

Site Status

St Augustine's Hospital

Durban, , South Africa

Site Status

Panorama Medi-Clinic

Grand Rapids, , South Africa

Site Status

UNITAS Hospital

Pretoria, , South Africa

Site Status

Vergelegen Medi-Clinic

Somerset West, , South Africa

Site Status

C.H.U. A Coruña

A Coruña, , Spain

Site Status

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

Hospital Universitario Vall Hebron

Barcelona, , Spain

Site Status

Policlinica Gipuzkoa

Donostia / San Sebastian, , Spain

Site Status

Hospital Clinico San Carlos

Madrid, , Spain

Site Status

Hospital La Paz

Madrid, , Spain

Site Status

Hospital Virgen de Arrixaca

Murcia, , Spain

Site Status

Hospital Marques de Valdecilla

Santander, , Spain

Site Status

Hospital Virgen Macarena

Seville, , Spain

Site Status

Complexo Hospitalario Universitario de Vigo

Vigo, , Spain

Site Status

Inselspital Bern

Bern, , Switzerland

Site Status

Klinik im Park

Zurich, , Switzerland

Site Status

London Chest Hospital

London, , United Kingdom

Site Status

St Thomas Hospital

London, , United Kingdom

Site Status

King's College Hospital NHS Foundation Trust

London, , United Kingdom

Site Status

St Mary's Hospital - Imperial College Healthcare NHS Trust, Hammersmith Hospital . Du Cane Road

London, , United Kingdom

Site Status

The James Cook University Hospital

Middlesbrough, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Belgium Canada Czechia Denmark Finland France Germany Greece Israel Italy Netherlands Norway Poland South Africa Spain Switzerland United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Schymik G, Lefevre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. JACC Cardiovasc Interv. 2015 Apr 27;8(5):657-69. doi: 10.1016/j.jcin.2014.10.026.

Reference Type DERIVED
PMID: 25946437 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-10

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The SOLACE-AU Clinical Trial
NCT01675596 COMPLETED NA
SAPIEN 3 Ultra EU PMS
NCT04860752 COMPLETED
Edwards SAPIEN 3 PPI Registry
NCT03497611 COMPLETED
FlexNav EU CE Mark Study
NCT03724812 COMPLETED NA
Sentinel Low Risk Registry
NCT04131127 COMPLETED